THIS NEW HOPE FOR BODY CONTROL ?

Experts are increasingly examining retatrutide, a promising drug from Eli Lilly, as a potential breakthrough in weight loss . Different than many existing approaches, retatrutide is a twin-action agonist targeting equally GLP-1 and GIP, chemicals that impact appetite and blood glucose control .